{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:05:06Z","timestamp":1767773106816,"version":"3.41.2"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>Sleep disorders are one of the most frequent non-motor symptoms of Parkinson's disease (PD), and the efficacy of dopaminergic agents remains controversial. Clinical randomized control trials for the treatment of sleep disorders in PD are limited. Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) improved motor symptoms and wearing-off in patients with PD. Patients with PD were reported to have dream-enacting behavior that was resolved after treatment with zonisamide. This study aimed to verify the safety and efficacy of zonisamide for sleep disorders and rapid eye movement (REM) sleep behavioral disorders using a mobile two-channel electroencephalography (EEG)\/electrooculography (EOG) recording system.<\/jats:p><jats:p><jats:bold>Methods and Analysis:<\/jats:bold>The present study is a randomized placebo-controlled trial to determine the efficacy of zonisamide for sleep disorders in patients with PD. This study was designed to be single-blind, but the subject allocation is randomized by an independent allocation manager via computer-generated block randomization. The subjects in the treatment group took zonisamide (25 mg per day) before bedtime for 28 days. The sleep index is analyzed using a portable EEG\/EOG recording system collected on two consecutive nights within 7 days prior to the intervention and reobtained on one night within 2 days after the 28-day administration of zonisamide. The amount of change in sleep efficiency before and after the 28-day administration will be compared between the zonisamide treatment group and placebo group concerning the primary endpoint. As for the secondary endpoint, the change in the ratio of other sleep parameters, including REM sleep without atonia, or sleep architecture will be evaluated.<\/jats:p><jats:p><jats:bold>Ethics and Dissemination:<\/jats:bold>The protocol was approved by the Nara Medical University Certified Review Board (CRB5200002). The trial was notified and registered with the Japan Registry of Clinical Trials (jRCTs051200160). Written informed consent will be obtained from every participant using informed consent approved by the CRB. The results of this trial will be disseminated through peer-reviewed scientific journals.<\/jats:p>","DOI":"10.3389\/fneur.2021.741307","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T09:24:16Z","timestamp":1639128256000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Hiroshi","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Isogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyoko","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Kasama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoki","family":"Nanaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kiriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/mdc3.12899","article-title":"Practical evaluation and management of insomnia in parkinson's disease: a review","volume":"7","author":"Wallace","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ncpneuro0775","article-title":"Sleep disturbances in patients with parkinsonism","volume":"4","author":"De Cock","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/mds.870050404","article-title":"Sleep disorders and sleep effect in Parkinson's disease","volume":"5","author":"Factor","year":"1990","journal-title":"Mov Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1389-9457(01)00127-7","article-title":"The prevalence of sleep disorders in patients with Parkinson's disease: a self-reported, community-based survey","volume":"3","author":"Oerlemans","year":"2002","journal-title":"Sleep Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/mds.27200","article-title":"Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease","volume":"32","author":"Sohail","year":"2017","journal-title":"Mov Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11940-017-0458-1","article-title":"Sleep disturbances in the prodromal stage of Parkinson disease","volume":"19","author":"Al-Qassabi","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/mds.24939","article-title":"Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jnnp.68.6.798a","article-title":"Sleep benefit in Parkinson's disease","volume":"68","author":"H\u00f6gl","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tins.2011.09.003","article-title":"New insights into the relationship between dopamine, beta oscillations and motor function","volume":"34","author":"Jenkinson","year":"2011","journal-title":"Trends Neurosci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Recover Study Group. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1007\/PL00007731","article-title":"Sleep disorders in Parkinson's disease","volume":"245","author":"Stocchi","year":"1998","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.03.029","article-title":"Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: a randomized trial","volume":"75","author":"Ahn","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","article-title":"Melatonin for sleep disturbances in Parkinson's disease","volume":"6","author":"Dowling","year":"2005","journal-title":"Sleep Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/mds.23168","article-title":"Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo","volume":"25","author":"Menza","year":"2010","journal-title":"Mov Disord"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1212\/01.WNL.0000158652.74601.48","article-title":"Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy","volume":"64","author":"Comella","year":"2005","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease \u2013 a randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","article-title":"Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study","volume":"254","author":"Medeiros","year":"2007","journal-title":"J Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","article-title":"Zonisamide improves motor function in parkinson disease: a randomized, double-blind study","volume":"68","author":"Murata","year":"2007","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/mds.26286","article-title":"Zonisamide improves wearing-off in Parkinson's disease: a randomized, double-blind study","volume":"30","author":"Murata","year":"2015","journal-title":"Mov Disord"},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ncn3.12026","article-title":"Randomized placebo-controlled trial of zonisamide in patients with Parkinson's disease","volume":"4","year":"2016","journal-title":"Neurol Clin Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e02026","DOI":"10.1002\/brb3.2026","article-title":"Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease","volume":"11","author":"Suzuki","year":"2021","journal-title":"Brain Behav"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ane.12016","volume":"194","author":"Brodie","year":"2012","journal-title":"Acta Neurol Scand Suppl."},{"key":"B26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000336441","article-title":"Nightmare-enacting behavior responding to zonisamide in early Parkinson's disease","volume":"4","author":"Kataoka","year":"2012","journal-title":"Case Rep Neurol"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1111\/ncn3.179","article-title":"Preliminary study of zonisamide monotherapy in de novo patients with early Parkinson's disease","volume-title":"Neurol Clin Neurosci","author":"Ikeda","year":"2015"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"B29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2012.03.022","article-title":"Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2","volume":"318","author":"Suzuki","year":"2012","journal-title":"J Neurol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.sleep.2009.05.007","article-title":"The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version","volume":"10","author":"Miyamoto","year":"2009","journal-title":"Sleep Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire\u2013a new diagnostic instrument","volume":"22","author":"Stiasny-Kolster","year":"2007","journal-title":"Mov Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mds.27862","article-title":"The movement disorder society nonmotor rating scale: initial validation study","volume":"35","author":"Chaudhuri","year":"2020","journal-title":"Mov Disord"},{"volume-title":"Manual for the Beck Depression Inventory, Second Edition (BDI-II)","year":"1996","author":"Beck","key":"B34"},{"key":"B35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2004.07.007","article-title":"The Parkinson fatigue scale","volume":"11","author":"Brown","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s41105-016-0078-2","article-title":"Inter-scorer reliability of sleep assessment using EEG and EOG recording system in comparison to polysomnography","volume":"15","author":"Nonoue","year":"2007","journal-title":"Sleep Biol Rhythms"},{"key":"B37","first-page":"101","article-title":"Evaluation of a portable two-channel electroencephalogram monitoring system to analyze sleep stages","volume":"2","author":"Kanemura","year":"2016","journal-title":"J Oral Sleep Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp.2006.100370","article-title":"Insomnia in Parkinson's disease: frequency and progression over time","volume":"78","author":"Gjerstad","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2869.2011.00944.x","article-title":"Validation of an automated wireless system to monitor sleep in healthy adults","volume":"21","author":"Shambroom","year":"2012","journal-title":"J Sleep Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","article-title":"Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls","volume":"123","author":"Eisensehr","year":"2000","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.ne.14.030191.000351","article-title":"Modulation of neural networks for behavior","volume":"14","author":"Harris-Warrick","year":"1991","journal-title":"Annu Rev Neurosci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.741307\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T22:41:55Z","timestamp":1699915315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.741307\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":41,"alternative-id":["10.3389\/fneur.2021.741307"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.741307","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"article-number":"741307"}}